Onconetix Inc (ONCO) Stock Price, Quote & News

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology

Sector: Healthcare

Phone: 513 620 4101

Website: www.onconetix.com

Address:

201 East Fifth Street, Suite 1900, Cincinnati, United States

VolcanicTrades Aug. 9 at 9:00 AM

$SLS congrats sella bulls. You guys deserve it. Hope the story keeps getting sweeter. Here. I have a feeling $ONCO and $GLMD will be on a similar route soon. Good luck

1 · Reply

Gigi96 Aug. 7 at 4:42 PM

$ONCO monday take off

1 · Reply

drweinerdog1 Aug. 7 at 1:44 PM

$ONCO I will buy more at .77 for the next pump and dump

0 · Reply

URANIUM77 Aug. 7 at 12:54 PM

$ONCO it is coming,load up.

0 · Reply

rubiconjay Aug. 7 at 12:22 PM

$ONCO $MSS $ZCMD Patience Jedi 💯 📈

0 · Reply

VolcanicTrades Aug. 6 at 9:02 PM

$GLMD swing play. $ONCO swing play

0 · Reply

VolcanicTrades Aug. 6 at 6:57 PM

$CELZ $SPY oh yeah. Watching $ONCO $CSAI

0 · Reply

URANIUM77 Aug. 6 at 5:53 PM

$SPCX $ONCO $TRNR $ISPC $PPCB It is happening now. Load up and Hold strong

1 · Reply

Adamwys Aug. 6 at 5:03 PM

$ONCO hello are you awake?

0 · Reply

URANIUM77 Aug. 6 at 3:21 PM

$ONCO 🔥The game is on 🔥

0 · Reply

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Aug 5, 2026, 8:30 AM EDT - 4 days ago

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Jul 7, 2026, 9:00 AM EDT - 4 weeks ago

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Jun 24, 2026, 8:30 AM EDT - 6 weeks ago

Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Jun 19, 2026, 7:00 PM EDT - 7 weeks ago

Onco-Innovations Announces Non-Brokered LIFE Offering

Jun 19, 2026, 6:00 PM EDT - 7 weeks ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Jun 16, 2026, 6:00 PM EDT - 7 weeks ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Onconetix Registration statement: Registration filing

2026-06-09T10:06:30.000Z - 2 months ago

Onconetix files to sell 100M shares of common stock for holders

2026-05-20T23:50:10.000Z - 2 months ago

Onconetix Inc trading halted, news pending

2026-05-19T12:39:58.000Z - 2 months ago

Onconetix announces 1-for-10 reverse stock split

May 19, 2026, 8:00 AM EDT - 2 months ago

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

2026-05-19T11:47:20.000Z - 2 months ago

Realbotix expects transaction with Onconetix to close by October

May 19, 2026, 7:30 AM EDT - 2 months ago

Realbotix Provides Update on Nasdaq Listing

May 13, 2026, 9:25 AM EDT - 3 months ago

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Onconetix Registration statement: Registration filing

2026-04-28T20:18:54.000Z - 3 months ago

Onconetix files to sell 25M shares of common stock for holders

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Onconetix Registration statement: Registration filing

Apr 9, 2026, 8:30 AM EDT - 4 months ago

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Apr 2, 2026, 8:30 AM EDT - 4 months ago

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

2026-03-31T13:13:26.000Z - 4 months ago

Onconetix CEO Karina Fedasz to step down, David White to succeed

ARTW

Mar 31, 2026, 8:30 AM EDT - 4 months ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 30, 2026, 8:00 AM EDT - 4 months ago

Onconetix Proxy statement: Proxy filing

Mar 25, 2026, 12:47 PM EDT - 4 months ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

2026-03-24T23:50:18.000Z - 4 months ago

Onconetix Inc trading halted, news pending

2026-03-23T13:12:26.000Z - 4 months ago

Onconetix announces 1-for-5 reverse stock split

Mar 23, 2026, 8:30 AM EDT - 4 months ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Onconetix Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Onconetix Annual report: Q4 2025

2026-02-12T13:27:43.000Z - 6 months ago

Onconetix to acquire Realbotix LLC in all-stock transaction

Feb 12, 2026, 8:00 AM EST - 6 months ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 6 months ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Jan 2, 2026, 7:00 AM EST - 7 months ago

Onconetix Proxy statement: Proxy Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 9 months ago

Onconetix Proxy statement: Proxy Filing

2025-11-04T21:45:43.000Z - 9 months ago

Onconetix files to sell 22.07M shares of common stock for holders

Nov 4, 2025, 7:00 AM EST - 9 months ago

Onconetix Registration statement: Registration Filing

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Onconetix Proxy statement: Proxy Filing

Oct 16, 2025, 8:00 AM EDT - 10 months ago

Onconetix Registration statement: Registration Filing

2025-10-16T10:10:38.000Z - 10 months ago

Onconetix files to sell 5.1M shares of common stock for holders

2025-09-26T12:40:45.000Z - 11 months ago

Onconetix announces financing through private placement, debt settlement

VERU

Sep 26, 2025, 8:30 AM EDT - 11 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

2025-09-26T12:20:26.000Z - 11 months ago

Onconetix, Ocuvex announce mutual termination of merger agreement

Sep 26, 2025, 8:15 AM EDT - 11 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

2025-09-22T12:10:57.000Z - 11 months ago

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

Sep 22, 2025, 8:00 AM EDT - 11 months ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

2025-07-16T12:21:02.000Z - 1 year ago

Onconetix, Ocuvex execute definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 1 year ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

2025-06-16T12:25:20.000Z - 1 year ago

Onconetix receives positive decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 1 year ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

2025-06-12T23:50:23.000Z - 1 year ago

Onconetix Inc trading halted, news pending

2025-06-11T15:35:06.000Z - 1 year ago

Onconetix announces 1-for-85 reverse stock split

Jun 11, 2025, 11:30 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

May 22, 2025, 4:50 PM EDT - 1 year ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 10:00 AM EDT - 1 year ago

Onco-Innovations Uplists to Cboe Canada

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Feb 7, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 11, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Oct 3, 2024, 4:45 PM EDT - 2 years ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 2 years ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Sep 20, 2024, 11:45 AM EDT - 2 years ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 3, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jul 15, 2024, 6:00 AM EDT - 2 years ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 2 years ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Proxy statement: Proxy Filing

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Jan 21, 2024, 7:00 AM EST - 2 years ago

Onconetix Slides: Corporate presentation

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Nov 2, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 1, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Oct 30, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Issues Letter to Shareholders

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Aug 28, 2023, 4:30 PM EDT - 3 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 3, 2023, 1:02 PM EDT - 3 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Jul 31, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 25, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 17, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 6, 2023, 5:05 PM EDT - 3 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

VolcanicTrades Aug. 9 at 9:00 AM

$SLS congrats sella bulls. You guys deserve it. Hope the story keeps getting sweeter. Here. I have a feeling $ONCO and $GLMD will be on a similar route soon. Good luck

1 · Reply

Gigi96 Aug. 7 at 4:42 PM

$ONCO monday take off

1 · Reply

drweinerdog1 Aug. 7 at 1:44 PM

$ONCO I will buy more at .77 for the next pump and dump

0 · Reply

URANIUM77 Aug. 7 at 12:54 PM

$ONCO it is coming,load up.

0 · Reply

rubiconjay Aug. 7 at 12:22 PM

$ONCO $MSS $ZCMD Patience Jedi 💯 📈

0 · Reply

VolcanicTrades Aug. 6 at 9:02 PM

$GLMD swing play. $ONCO swing play

0 · Reply

VolcanicTrades Aug. 6 at 6:57 PM

$CELZ $SPY oh yeah. Watching $ONCO $CSAI

0 · Reply

URANIUM77 Aug. 6 at 5:53 PM

$SPCX $ONCO $TRNR $ISPC $PPCB It is happening now. Load up and Hold strong

1 · Reply

Adamwys Aug. 6 at 5:03 PM

$ONCO hello are you awake?

0 · Reply

URANIUM77 Aug. 6 at 3:21 PM

$ONCO 🔥The game is on 🔥

0 · Reply

URANIUM77 Aug. 6 at 1:57 PM

$ONCO This stock is the cheapest on the entire NASDAQ right now. Fantastic news today.

0 · Reply

URANIUM77 Aug. 6 at 1:09 PM

$SPCX $ONCO $TRNR $ISPC $PPCB Monster news now target $20 ++++++ https://finance.yahoo.com/technology/ai/articles/onconetix-acquisition-target-realbotix-secures-123000606.html

0 · Reply

URANIUM77 Aug. 6 at 11:11 AM

$ONCO The global artificial intelligence (AI) robots market is valued at roughly USD 20 billion to USD 26 billion, and is projected to expand rapidly toward over USD 120 billion to USD 180 billion by the early 2030s, driven by major advancements in physical AI and labor shortages.

0 · Reply

Gigi96 Aug. 6 at 10:26 AM

$ONCO it could explode today

1 · Reply

URANIUM77 Aug. 6 at 10:20 AM

$ONCO There are enormous quantities of illegal naked shorted shares here. Short is soon ruined Load up and Hold strong

0 · Reply

Siara1620 Aug. 6 at 8:40 AM

$ONCO A success would be $2. The real value of the junk is $0.

0 · Reply

VolcanicTrades Aug. 6 at 8:34 AM

$ONCO

0 · Reply

URANIUM77 Aug. 6 at 8:18 AM

$ONCO Cash in the bank currently amounts to NOK 10 per share, plus the merger, plus the cancer company they own in Switzerland. Target: $20.

0 · Reply

Gigi96 Aug. 6 at 6:31 AM

$ONCO very

0 · Reply

VolcanicTrades Aug. 6 at 5:27 AM

$ONCO this a name that can see an extremely explosive move with news. Over 1.26 can see as high as 3.74 in a hurry or much more. The potential is in the 📈 hopefully we see it this week! Keep eyes 👀 $SPY

1 · Reply

VolcanicTrades Aug. 6 at 5:03 AM

$ONCO I mean we are in August so there should be news imminent soon

0 · Reply

Adamwys Aug. 6 at 12:39 AM

$ONCO dilution time at $0.98 Series F

0 · Reply

Market Cap	1.02M
Revenue (ttm)	820,000.00
Net Income (ttm)	-14.03M
EPS (ttm)	N/A
PE Ratio	0.02
Forward PE	N/A
Profit Margin	-1,710.98%
Debt to Equity Ratio	0.00

Volume	104,800
Avg Vol	643,692
Day's Range	N/A - N/A
Shares Out	1.14M
Stochastic %K	66%
Beta	2.69
Analysts	Strong Buy
Price Target	N/A